{
  "paper_metadata": {
    "pmid": "36003761",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information specifically for the BRCA2 gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": null,
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 41,
        "demographics": "Women with early onset breast cancer",
        "phenotype": "Breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 41,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Not specified in the paper.",
        "assays": []
      },
      "segregation_data": "Not specified in the paper.",
      "population_frequency": "Not specified in the paper.",
      "evidence_level": "Not specified in the paper.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The paper mentions that 41 of 226 individuals had pathogenic variants in BRCA2.",
      "key_quotes": [
        "Germline P and LP variants in TP53 gene were present in 30.5% of all individuals (69 of 226), 20.8% in BRCA1 (47 of 226), and 18.1% in BRCA2 gene (41 of 226)."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Only one variant was reported for BRCA2, and no specific individual-level penetrance data was available."
  }
}